Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUREMETS: Sunitinib + FOLFIRI for Rectal Cancer
NCT00936832Phase 2Withdrawn
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in rectal cancer, sponsored by Fédération Francophone de Cancérologie Digestive. Planned start Apr 2009; status: withdrawn.
02
Drugs
sunitinib
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00936832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936832.